Crossmark

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

Crossref DOI link: https://doi.org/10.1038/S41598-019-40241-1

Published: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Lian, Shu

Xie, Ruizhi

Ye, Yuying

Lu, Yusheng

Cheng, Yunlong

Xie, Xiaodong

Li, Shuhui

Jia, Lee
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81703555, U1505225, 81773063)

China Postdoctoral Science Foundation (2017M620268)

Chinese Ministry of Science and Technology | Department of S and T for Social Development (2015CB931804)
License Information

Text and Data Mining valid from 2019-03-14
More Information

Article History

Received: 14 August 2018

Accepted: 7 February 2019

First Online: 14 March 2019

Competing Interests

: The authors declare no competing interests.